Successful treatment of symptomatic first-degree atrioventricular block after Occlutech Figulla Flex II atrial septal defect occluder placement


      Given the rarity of significant first-degree atrioventricular block (AVB) after Occlutech Figulla Flex II atrial septal defect occluder (OFF II, Occlutech International AB, Helsingborg, Sweden) placement, its management and predictors of recovery have not been established. We report a 9-year-old boy who developed significant first-degree AVB a day after OFF II deployment. Thereafter, oral prednisolone was initiated at 1.5 mg/kg/day. On day 2 of steroid treatment, normal sinus rhythm without conduction delays was occasionally observed, while the prolonged PR interval on the exercise stress test was ameliorated. After 5 days of steroid administration, normal sinus rhythm without conduction delays was completely achieved. An increase in the frequency of normal sinus rhythm and the absence of conduction delays on electrocardiogram monitoring and exercise stress test play an important role in predicting recovery from prolonged PR interval. Thus, steroid treatment can be effective and should be considered for patients who develop first-degree AVB after undergoing OFF II placement for transcatheter device closure of atrial septal defect.


      To read this article in full you will need to make a payment


        • Du Z.D.
        • Hijazi Z.M.
        • Kleinman C.S.
        • Silverman N.H.
        • Larntz K.
        Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: Results of a multicenter nonrandomized trial.
        J Am Coll Cardiol. 2002; 39: 1836-1844
        • Suda K.
        • Raboisson M.J.
        • Piette E.
        • Dahdah N.S.
        • Miró J.
        Reversible atrioventricular block associated with closure of atrial septal defects using the Amplatzer device.
        J Am Coll Cardiol. 2004; 43: 1677-1682
        • Wang Y.
        • Hua Y.
        • Li L.
        • Wang X.
        • Qiao L.
        • Shi X.
        • Hua J.
        • Qu Y.
        • Mu D.
        Risk factors and prognosis of atrioventricular block after atrial septum defect closure using the Amplatzer device.
        Pediatr Cardiol. 2014; 35: 550-555
        • Kitano M.
        • Fujimoto K.
        • Kato A.
        • Kurosaki K.I.
        • Shiraishi I.
        Efficacy and safety of the atrial septal defect closure for patients with absent or malaligned aortic rim using a Figulla Flex II device flared and straddling behind the aorta.
        Congenit Heart Dis. 2021; 16: 269-283
        • Barold S.S.
        • Ilercil A.
        • Leonelli F.
        • Herweg B.
        First-degree atrioventricular block. Clinical manifestations, indications for pacing, pacemaker management & consequences during cardiac resynchronization.
        J Interv Card Electrophysiol. 2006; 17: 139-152
        • Follansbee C.W.
        • Beerman L.
        • Arora G.
        Marked first-degree atrioventricular block and pseudo-pacemaker syndrome in a pediatric patient.
        Pediatr Cardiol. 2018; 39: 637-639
        • Lin S.M.
        • Hwang H.K.
        • Chen M.R.
        Amplatzer septal occluder-induced transient complete atrioventricular block.
        J Formos Med Assoc. 2007; 106: 1052-1056
        • Haas N.A.
        • Soetemann D.B.
        • Ates I.
        • Baspinar O.
        • Ditkivskyy I.
        • Duke C.
        • Godart F.
        • Lorber A.
        • Oliveira E.
        • Onorato E.
        • Pac F.
        • Promphan W.
        • Riede F.T.
        • Roymanee S.
        • Sabiniewicz R.
        • et al.
        Closure of secundum atrial septal defects by using the Occlutech occluder devices in more than 1300 patients: The IRFACODE project: A retrospective case series.
        Catheter Cardiovasc Interv. 2016; 88: 571-581